1643TiP First-in-human dose-escalation and expansion study (MITOPE) to evaluate mitochondrial PRX3 inhibition by RSO-021 in patients with mesothelioma and other advanced solid tumors

Autor: Dulloo, S., Fennell, D.A., Szlosarek, P.W., Thistlethwaite, F., Lord, S., Rahman, N.M., Greystoke, A., Cunniff, B., Dzialo, J., Poile, C., Panchal, R., Duncan, J., Graham, P., Bexon, A.S., Naumov, G., Spicer, J.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1292-S1293
Databáze: ScienceDirect